{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:10:16Z","timestamp":1783944616743,"version":"3.55.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Clinical and Translational Research Project of Anhui Province","award":["202427b10020127"],"award-info":[{"award-number":["202427b10020127"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This study aimed to investigate how diabetes mellitus (DM) influences the efficacy of early tirofiban administration after intravenous thrombolysis in patients with acute ischaemic noncardioembolic stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>This was a post-hoc analysis of the ASSET-IT (Advancing Stroke Safety and Efficacy through Early Tirofiban Administration after Intravenous Thrombolysis) trial. Patients were categorised into DM and non-DM groups based on baseline diabetes history. The primary efficacy outcome was an excellent functional outcome at 90\u00a0days, defined as an mRS score of 0\u20131. Safety outcomes included sICH within 36\u00a0h, any ICH and all-cause mortality within 90\u00a0days. The effect of diabetes on treatment outcomes was assessed using multivariable regression models adjusting for relevant confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 832 patients at 38 centres were randomised in the ASSET-IT trial (414 to tirofiban, 418 to placebo). The median age was 69\u00a0years (IQR, 59\u201376); 301 (36.2%) were women. Overall, 191 patients (23.0%) had diabetes mellitus. Among patients without diabetes, an excellent functional outcome at 90\u00a0days occurred in 69.0% of patients in the tirofiban group and 55.8% in the placebo group, whereas among patients with diabetes, the corresponding rates were 55.0% and 52.0%, respectively. The nominal P value for the treatment-by-diabetes interaction was .009. The 90-day mortality was higher in the DM group receiving tirofiban (6.6% vs 2.0%; RR, 3.79; 95% CI, 0.84\u201317.05; P\u00a0=\u00a0.082) but not in the non-DM group (3.4% vs 4.4%; RR, 0.82; 95% CI, 0.40\u20131.70; P\u00a0=\u00a0.597).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Exploratory post-hoc findings from the ASSET-IT trial suggest that the association between early tirofiban administration after intravenous thrombolysis and 90-day functional outcomes may differ according to diabetes status. These hypothesis-generating observations require confirmation in prospective studies with pre-specified subgroup analyses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/esj\/aakag076","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:20:54Z","timestamp":1783941654000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of Admission Diabetes History on Safety and Efficacy of Early Tirofiban Infusion after Intravenous Thrombolysis in Ischaemic Stroke: a post-hoc analysis of the ASSET-IT trial"],"prefix":"10.1093","volume":"11","author":[{"given":"Li","family":"Wang","sequence":"first","affiliation":[{"name":"Cheeloo College of Medicine, Shandong University , Jinan 250000 ,","place":["China"]},{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunrong","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuerong","family":"Chen","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Anhui Medical University, Anhui Medical University , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyou","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlong","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangping","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Cheeloo College of Medicine, Shandong University , Jinan 250000 ,","place":["China"]},{"name":"Department of Neurology, First Affiliated Hospital of the University of Science and Technology of China, Division of Life Sciences and Medicine, University of Science and Technology of China , Hefei 230001 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"2026071307204960200_ref1","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","article-title":"Stroke","volume":"403","author":"Hilkens","year":"2024","journal-title":"Lancet"},{"key":"2026071307204960200_ref2","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"2026071307204960200_ref3","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.1007\/s00415-022-11112-z","article-title":"Prevalence and in-hospital outcomes of diabetes among acute ischemic stroke patients in China: results from the Chinese Stroke Center Alliance","volume":"269","author":"Hu","year":"2022","journal-title":"J Neurol"},{"key":"2026071307204960200_ref4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jns.2018.03.022","article-title":"Hyperglycemia predicts unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis among a Chinese population: a prospective cohort study","volume":"388","author":"Lin","year":"2018","journal-title":"J Neurol Sci"},{"key":"2026071307204960200_ref5","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1161\/STROKEAHA.111.675918","article-title":"Glycosylated hemoglobin A1 predicts risk for symptomatic hemorrhage after thrombolysis for acute stroke","volume":"44","author":"Rocco","year":"2013","journal-title":"Stroke"},{"key":"2026071307204960200_ref6","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1001\/archneurol.2010.210","article-title":"Association of admission blood glucose and outcome in patients treated with intravenous thrombolysis: results from the Safe Implementation of Treatments in Stroke International Stroke Thrombolysis Register (SITS-ISTR)","volume":"67","author":"Ahmed","year":"2010","journal-title":"Arch Neurol"},{"key":"2026071307204960200_ref7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2377-7-33","article-title":"Increased hemorrhagic transformation and altered infarct size and localization after experimental stroke in a rat model type 2 diabetes","volume":"7","author":"Ergul","year":"2007","journal-title":"BMC Neurol"},{"key":"2026071307204960200_ref8","first-page":"718","article-title":"Hyperglycemia: a predictor of poor prognosis in acute stroke","volume":"27","author":"Mazighi","year":"2001","journal-title":"Diabetes Metab"},{"key":"2026071307204960200_ref9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/jcbfm.2010.210","article-title":"Hyperglycaemia and infarct size in animal models of middle cerebral artery occlusion: systematic review and meta-analysis","volume":"31","author":"MacDougall","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"2026071307204960200_ref10","doi-asserted-by":"publisher","first-page":"095008","DOI":"10.1088\/1361-6579\/ae0675","article-title":"Chronic hyperglycaemia is associated with vascular gain impairment in microangiopathic lacunar stroke","volume":"46","author":"Lakatos","year":"2025","journal-title":"Physiol Meas"},{"key":"2026071307204960200_ref11","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1161\/01.STR.31.6.1402","article-title":"Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia","volume":"31","author":"Abumiya","year":"2000","journal-title":"Stroke"},{"key":"2026071307204960200_ref12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2503678","article-title":"Early tirofiban infusion after intravenous thrombolysis for stroke","volume":"393","author":"Tao","year":"2025","journal-title":"N Engl J Med"},{"key":"2026071307204960200_ref13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.27207","article-title":"Efficacy and safety of dual antiplatelet treatment up to 72\u2009hours in acute ischemic stroke stratified by glycemic status","volume":"98","author":"Zhou","year":"2025","journal-title":"Ann Neurol"},{"key":"2026071307204960200_ref14","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1056\/NEJMe1910813","article-title":"Antiplatelet therapy in patients with coronary disease and type 2 diabetes","volume":"381","author":"Bates","year":"2019","journal-title":"New Engl J Med"},{"key":"2026071307204960200_ref15","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1007\/s00415-016-8181-5","article-title":"Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population","volume":"263","author":"Yi","year":"2016","journal-title":"J Neurol"},{"key":"2026071307204960200_ref16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11239-014-1165-3","article-title":"Reticulated platelets and antiplatelet therapy response in diabetic patients","volume":"40","author":"Mijovic","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"2026071307204960200_ref17","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1172\/JCI92450","article-title":"Neutrophil-derived S100 calcium-binding proteins A8\/A9 promote reticulated thrombocytosis and atherogenesis in diabetes","volume":"127","author":"Kraakman","year":"2017","journal-title":"J Clin Invest"},{"key":"2026071307204960200_ref18","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJM199805213382110","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade in unstable coronary disease","volume":"338","author":"Chesebro","year":"1998","journal-title":"New Engl J Med"},{"key":"2026071307204960200_ref19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2165\/00129784-200303020-00002","article-title":"Therapeutic potential of platelet glycoprotein IIb\/IIIa receptor antagonists in the management of ischemic stroke","volume":"3","author":"Lapchak","year":"2003","journal-title":"Am J Cardiovasc Drug"},{"key":"2026071307204960200_ref20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bbi.2017.11.019","article-title":"Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia-reperfusion injury by strengthening the blood-brain barrier function and anti-thrombo-inflammatory property","volume":"69","author":"Chen","year":"2018","journal-title":"Brain Behav Immun"},{"key":"2026071307204960200_ref21","doi-asserted-by":"publisher","DOI":"10.26420\/thrombhaemostres.2023.1090","article-title":"A review of antithrombotic agents for the treatment of ischemic stroke","volume":"7","author":"Ng","year":"2023","journal-title":"Thromb Haemost Res"},{"key":"2026071307204960200_ref22","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s40265-025-02222-9","article-title":"Tirofiban in acute ischemic stroke: mechanistic rationale, clinical advances, and emerging therapeutic strategies","volume":"85","author":"Jiang","year":"2025","journal-title":"Drugs"},{"key":"2026071307204960200_ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063170","article-title":"PAI-1 in diabetes: pathophysiology and role as a therapeutic target","volume":"22","author":"Altalhi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026071307204960200_ref24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4103\/bc.bc_93_23","article-title":"Safety and efficacy of tirofiban in preventing neurological deterioration in acute ischemic stroke (TREND): protocol for an investigator-initiated, multicenter, prospective, randomized, open-label, masked endpoint trial","volume":"10","author":"Wang","year":"2024","journal-title":"Brain Circ"},{"key":"2026071307204960200_ref25","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/cns.14058","article-title":"Factors affecting the outcomes of tirofiban after endovascular treatment in acute ischemic stroke: experience from a single center","volume":"29","author":"Wang","year":"2023","journal-title":"CNS Neurosci Ther"}],"container-title":["European Stroke Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/11\/7\/aakag076\/68763791\/aakag076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/esj\/article-pdf\/11\/7\/aakag076\/68763791\/aakag076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:20:55Z","timestamp":1783941655000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/esj\/article\/doi\/10.1093\/esj\/aakag076\/8733209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,6]]}},"URL":"https:\/\/doi.org\/10.1093\/esj\/aakag076","relation":{},"ISSN":["2396-9873","2396-9881"],"issn-type":[{"value":"2396-9873","type":"print"},{"value":"2396-9881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7]]},"article-number":"aakag076"}}